Drug intelligence / Profile preview

shunqi huatan decoction

Development stage: Unknown
Lead developer: Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Modality: Small Molecules
Administration: Oral

Overview

Shunqi Huatan Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. It is specifically designed to treat carotid atherosclerosis in patients diagnosed with the TCM syndrome of qi stagnation and phlegm coagulation. The therapy is administered as granules and aims to reduce carotid intima-media thickness (CIMT) and the size of atherosclerotic plaques. By addressing the underlying TCM pathologies of qi obstruction and phlegm accumulation, the decoction is intended to improve vascular health and prevent the progression of atherosclerotic disease.

Other names: Shunqi Huatan Tang

Beyond the preview

Go deeper on shunqi huatan decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on shunqi huatan decoction.

Explore the full profile